In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Origin Materials Inc (NASDAQ: ORGN) was $0.21 for the day, down -8.37% from the previous closing price of $0.23. In other words, the price has decreased by -$8.37 from its previous closing price. On the day, 1.82 million shares were traded. ORGN stock price reached its highest trading level at $0.2335 during the session, while it also had its lowest trading level at $0.2077.
Ratios:
Our analysis of ORGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.28 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for the company, BofA Securities on January 14, 2025, Downgraded its rating to Underperform and sets its target price to $1.50 from $2.50 previously.
On August 16, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $1.35 to $3.
Craig Hallum Downgraded its Buy to Hold on August 11, 2023, while the target price for the stock was maintained at $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 26 ’25 when MATTHEW PLAVAN bought 40,000 shares for $0.20 per share.
Lee Joshua C. sold 35,000 shares of ORGN for $6,912 on Dec 29 ’25. The General Counsel now owns 606,884 shares after completing the transaction at $0.20 per share. On Dec 24 ’25, another insider, Lee Joshua C., who serves as the General Counsel of the company, sold 29,000 shares for $0.23 each. As a result, the insider received 6,609 and left with 641,884 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 32129802 and an Enterprise Value of -17378980. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.28 while its Price-to-Book (P/B) ratio in mrq is 0.11. Its current Enterprise Value per Revenue stands at -0.692 whereas that against EBITDA is 0.33.
Stock Price History:
The Beta on a monthly basis for ORGN is 0.99, which has changed by -0.77843136 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, ORGN has reached a high of $1.17, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is -47.75%, while the 200-Day Moving Average is calculated to be -62.17%.
Shares Statistics:
ORGN traded an average of 1.78M shares per day over the past three months and 2948070 shares per day over the past ten days. A total of 150.53M shares are outstanding, with a floating share count of 143.72M. Insiders hold about 7.41% of the company’s shares, while institutions hold 10.71% stake in the company. Shares short for ORGN as of 1767139200 were 7108635 with a Short Ratio of 3.99, compared to 1764288000 on 3900857. Therefore, it implies a Short% of Shares Outstanding of 7108635 and a Short% of Float of 4.68.
